Special Issues
Molecules publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Metal-Based Drugs: Past, Present and Future, 3rd Edition
Deadline: 30 September 2026
Discovery and Development of Anti-Cancer Drugs: From Signalling Pathways to Molecular Mechanisms
Deadline: 30 September 2026
Chemical Biology in Europe
Deadline: 30 September 2026
Molecular Biophysics of Viral Proteins
Deadline: 30 September 2026
Interaction Between Biomacromolecules and Dietary Antioxidants—Characterisation and Physiological Significance
Deadline: 30 September 2026
Carbohydrate Chemistry and Synthesis: Innovative Antibacterial Solutions
Deadline: 30 September 2026
Exosomes in Tumor Therapy: Molecular Mechanisms and Therapeutic Applications
Deadline: 30 September 2026
Biomarker for Molecular-Targeted Cancer Therapy
Deadline: 10 October 2026
Trends in Biosensors for Biomedical Applications
Deadline: 31 October 2026
Targeting Cell Signaling Pathways in Drug Discovery
Deadline: 31 October 2026
Advances in Chemical Research on Biomarkers—Experimental and Computational Approaches
Deadline: 31 October 2026
Proteomics in Autoimmune Disorders: From Immune Dysregulation to Therapeutic Targets
Deadline: 31 October 2026
of 4

